Company Name or Ticker Symbol
Search for other Categories

Apollo Endosurgery, inc.  (LPTN)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

LPTN's Revenue Year on Year Growth by Quarter and Year

Apollo Endosurgery, inc.'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
LPTN Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 64.83 0.01 0.92
III Quarter September - 0.02 0.06 1.11
II Quarter June - 0.01 0.75 1.33
I Quarter March 14.62 0.01 0.78 1.72
FY   14.62 64.87 1.60 5.08

Financial Statements
Apollo Endosurgery, inc.'s first quarter 2017 Revenue $ 14.62 millions LPTN's Income Statement
Apollo Endosurgery, inc.'s first quarter 2016 Revenue $ 0.01 millions Quarterly LPTN's Income Statement
LPTN's Growth by Division See LPTN's Growth by Segment

LPTN Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 648200 % -98.91 % -54 %
III Quarter September - -66.67 % -94.59 % -56.47 %
II Quarter June - -98.67 % -43.61 % -34.16 %
I Quarter March 146120 % -98.72 % -54.65 % 44.54 %
FY   - 3954.38 % -68.5 % -

LPTN Revenue Growth Comment
Apollo Endosurgery, inc. achieved in the first quarter, above Company average Revenue surge of 146120% year on year, to $ 14.62 millions.

According to the results reported in the first quarter, Apollo Endosurgery, inc. achieved the best Revenue growth in Biotechnology & Drugs industry. While Apollo Endosurgery, inc.' s Revenue doubling of 146120% ranks overall at the positon no. 6 in the first quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #2
S&P 500 #6
Revenue Y/Y Growth Statistics
High Average Low
927699.37 % 71952.7 % -99.24 %
(Dec 31 2016)   (Dec 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LPTN's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LPTN's Competitors
Revenue Growth for Apollo Endosurgery, inc.'s Suppliers
Revenue Growth for LPTN's Customers

You may also want to know
LPTN's Annual Growth Rates LPTN's Profitability Ratios LPTN's Asset Turnover Ratio LPTN's Dividend Growth
LPTN's Roe LPTN's Valuation Ratios LPTN's Financial Strength Ratios LPTN's Dividend Payout Ratio
LPTN's Roa LPTN's Inventory Turnover Ratio LPTN's Growth Rates LPTN's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Apollo Endosurgery, inc.  152,085.68 %$ 152,085.679 millions
Second Sight Medical Products Inc  95,721.46 %$ 95,721.462 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
KDUS's Profile
Stock Price
KDUS's Financials
KDUS's Expectations
Business Description
Charts & Quotes
KDUS's News
KDUS's Competitors
Customers & Markets
Economic Indicators
KDUS's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com